
Fluidigm Corporation FLDM
Fluidigm Corporation ROA 2011-2026 | FLDM
ROA Jährlich Fluidigm Corporation
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| -16.33 | -24.47 | -19.43 | -21.07 | -24.8 | -14.37 | -12.96 | -14.14 | -16.73 | -28.33 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -12.96 | -28.33 | -19.26 |
ROA anderer Aktien in der Diagnostik & Forschung
| Name | ROA | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
-51.41 | - | -6.23 % | $ 30.6 M | ||
|
Burning Rock Biotech Limited
BNR
|
-34.96 | $ 15.85 | -2.49 % | $ 171 M | ||
|
Agilent Technologies
A
|
11.3 | $ 115.06 | -0.29 % | $ 35 B | ||
|
Aspira Women's Health
AWH
|
-234.24 | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
-103.93 | - | -13.05 % | $ 7.29 M | ||
|
BioNano Genomics
BNGO
|
-35.87 | $ 1.13 | -2.59 % | $ 6.15 M | ||
|
Chembio Diagnostics
CEMI
|
-37.2 | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
-6670.82 | - | - | $ 9.42 M | ||
|
DermTech
DMTK
|
-82.74 | - | -11.32 % | $ 2.94 M | ||
|
CareDx, Inc
CDNA
|
-5.17 | $ 16.05 | -3.83 % | $ 855 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
-0.77 | - | - | $ 562 M | ||
|
Akumin
AKU
|
-8.88 | - | -17.87 % | $ 25.9 M | ||
|
Enzo Biochem
ENZ
|
-30.41 | - | -8.98 % | $ 14.8 K | ||
|
Co-Diagnostics
CODX
|
-189.54 | $ 4.4 | 101.83 % | $ 5.85 M | ||
|
Exact Sciences Corporation
EXAS
|
-3.55 | - | - | $ 19.8 B | ||
|
Accelerate Diagnostics
AXDX
|
-22.47 | - | -61.36 % | $ 2.46 M | ||
|
Castle Biosciences
CSTL
|
3.43 | $ 23.13 | -1.28 % | $ 642 M | ||
|
Global Cord Blood Corporation
CO
|
5.87 | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
-34.28 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-33.12 | - | 0.12 % | $ 80.1 M | ||
|
Interpace Biosciences
IDXG
|
72.63 | $ 2.3 | - | $ 10.2 M | ||
|
Charles River Laboratories International
CRL
|
-2.02 | $ 175.65 | 0.06 % | $ 8.71 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
4.72 | - | - | $ 10.7 B | ||
|
Danaher Corporation
DHR
|
4.33 | $ 189.61 | -1.7 % | $ 135 B | ||
|
Heska Corporation
HSKA
|
-3.4 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
-121.47 | - | -20.0 % | $ 1.06 M | ||
|
Medpace Holdings
MEDP
|
22.84 | $ 493.53 | -1.59 % | $ 14.2 B | ||
|
Illumina
ILMN
|
-19.4 | $ 120.93 | -2.22 % | $ 19.2 B | ||
|
Fulgent Genetics
FLGT
|
-3.5 | $ 14.43 | -3.93 % | $ 436 M | ||
|
Myriad Genetics
MYGN
|
-51.78 | $ 4.35 | -2.03 % | $ 403 M | ||
|
NeoGenomics
NEO
|
-7.94 | $ 7.69 | -3.17 % | $ 985 M | ||
|
Guardant Health
GH
|
-20.67 | $ 78.6 | -9.83 % | $ 9.85 B | ||
|
QIAGEN N.V.
QGEN
|
6.76 | - | - | $ 10.6 B | ||
|
Anixa Biosciences
ANIX
|
-67.95 | $ 2.69 | -1.82 % | $ 87.3 K | ||
|
Biomerica
BMRA
|
-83.65 | $ 2.13 | -0.9 % | $ 4.89 M | ||
|
Invitae Corporation
NVTA
|
-5.11 | - | - | $ 21.2 M | ||
|
Koninklijke Philips N.V.
PHG
|
10.73 | $ 28.31 | 0.62 % | $ 20 B | ||
|
ICON Public Limited Company
ICLR
|
4.69 | $ 106.81 | 0.1 % | $ 8.81 B | ||
|
Laboratory Corporation of America Holdings
LH
|
4.77 | $ 260.93 | -4.51 % | $ 21.7 B | ||
|
Natera
NTRA
|
-39.28 | $ 193.03 | -4.91 % | $ 19 B | ||
|
Celcuity
CELC
|
-37.95 | $ 117.14 | -6.02 % | $ 5.48 B | ||
|
Lantheus Holdings
LNTH
|
10.49 | $ 80.59 | -1.03 % | $ 5.44 B | ||
|
Motus GI Holdings
MOTS
|
-178.14 | - | -34.28 % | $ 263 K | ||
|
Quest Diagnostics Incorporated
DGX
|
6.11 | $ 191.51 | -3.19 % | $ 21.3 B | ||
|
Neogen Corporation
NEOG
|
-31.71 | $ 9.42 | -6.13 % | $ 2.04 B | ||
|
ENDRA Life Sciences
NDRA
|
-182.35 | $ 4.94 | -6.97 % | $ 3.89 M | ||
|
Organovo Holdings
ONVO
|
-16.98 | - | -2.3 % | $ 19.4 M | ||
|
OpGen
OPGN
|
121.6 | - | -16.95 % | $ 1.54 M | ||
|
National Research Corporation
NRC
|
8.6 | $ 16.48 | -3.34 % | $ 369 M |